Tumors are not static entities; they evolve over time through a process called clonal evolution. As cancer cells divide, they accumulate additional genetic mutations, leading to the emergence of distinct subclones within the tumor. This genetic diversity contributes to tumor heterogeneity, making treatment more challenging as different subclones may respond differently to therapies.